BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 11991685)

  • 41. Inhibition of cyclooxygenase-2 by celecoxib reverses tumor-induced wasting.
    Davis TW; Zweifel BS; O'Neal JM; Heuvelman DM; Abegg AL; Hendrich TO; Masferrer JL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):929-34. PubMed ID: 14711936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever.
    Simmons DL; Wagner D; Westover K
    Clin Infect Dis; 2000 Oct; 31 Suppl 5():S211-8. PubMed ID: 11113025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
    Liao Z; Milas L; Komaki R; Stevens C; Cox JD
    Am J Clin Oncol; 2003 Aug; 26(4):S85-91. PubMed ID: 12902863
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cyclooxygenase 2 inhibitors and lung carcinoma].
    Spano JP; Chouahnia K; Morère JF
    Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
    Rao M; Yang W; Seifalian AM; Winslet MC
    Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is inhibition of cyclooxygenase required for the chemopreventive effect of NSAIDs in colon cancer? A model reconciling the current contradiction.
    Rigas B; Shiff SJ
    Med Hypotheses; 2000 Feb; 54(2):210-5. PubMed ID: 10790755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality.
    Rüegg C; Zaric J; Stupp R
    Ann Med; 2003; 35(7):476-87. PubMed ID: 14649330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COX-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs.
    Moore BC; Simmons DL
    Curr Med Chem; 2000 Nov; 7(11):1131-44. PubMed ID: 11032963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
    Backlund MG; Mann JR; Dubois RN
    Oncology; 2005; 69 Suppl 1():28-32. PubMed ID: 16210874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastro-intestinal lesions induced by non-steroidal anti-inflammatory drugs.
    Albu R; Dragomir P; Voiosu R
    Rom J Intern Med; 1998; 36(3-4):145-59. PubMed ID: 10822511
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanisms underlying chemoprevention of ovarian cancer.
    Mills GB
    Clin Cancer Res; 2002 Jan; 8(1):7-10. PubMed ID: 11801533
    [No Abstract]   [Full Text] [Related]  

  • 54. Potential role of selective COX-2 inhibitors in cancer management.
    Dang CT; Shapiro CL; Hudis CA
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M; Chaussade S
    Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action.
    Husain SS; Szabo IL; Tamawski AS
    Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back.
    Monnier Y; Zaric J; Rüegg C
    Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):31-8. PubMed ID: 15720233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclooxygenases and colon cancer.
    Kawai N; Tsujii M; Tsuji S
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():187-96. PubMed ID: 12432918
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What's in the future? New NSAIDs].
    Laufer S
    Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of cyclooxygenases in angiogenesis.
    Leahy KM; Koki AT; Masferrer JL
    Curr Med Chem; 2000 Nov; 7(11):1163-70. PubMed ID: 11032965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.